Introduction: Pseudostrabismus is a common diagnosis in a busy pediatric ophthalmology practice. This purpose of this study was to determine the prevalence of true strabismus in patients previously diagnosed with pseudostrabismus, to determine risk factors, and to examine the sensory outcome.
INTRODUCTION
The diagnosis of pseudostrabismus is applied when the ocular motility examination reveals that the visual axes are aligned in spite of an anatomical feature of the eyes, orbits or lids that creates a false appearance strabismus. In the absence of other ocular pathology, assigning the diagnosis of pseudostrabismus is medically equivalent to concluding that the child had a normal eye exam. The experienced clinician, however, knows that children diagnosed with pseudostrabismus can present later with true manifest strabismus, sometimes with associated amblyopia and loss of bifoveal fusion. Recognizing this later presentation and to aid in management decisions, this study was conducted to determine the prevalence of later occurrence of manifest strabismus in patients diagnosed with pseudostrabismus and to investigate the value of potential risk factors in predicting manifest strabismus. For those patients with pseudostrabismus who later developed manifest strabismus, we determined the prevalence of amblyopia at first presentation of manifest strabismus and assessed the final sensory and visual results.
SUBJECTS AND METHODS
This was a retrospective chart review of all patients from the authors' Children's Hospital New Orleans Louisiana clinic diagnosed with pseudostrabismus with at least one follow-up visit. All subjects were noted to have an apparent ocular deviation by either a family member, family friend, pediatrician, daycare provider/teacher, or general ophthalmologist. Patients with nystagmus, fundus pathology, or media opacities were excluded. All patients received a complete ophthalmological examination including ductions and versions, pupils, anterior segment examination by penlight, and fundus examination. Cycloplegic refractive error was determined for all patients with the Retinomax™ autorefractor or by streak retinoscopy. Cycloplegia was obtained by instillation of a drop of topical Proparacaine ® followed by a drop containing a mixture of 0.9% Cyclo- Ocular alignment was assessed at least twice at the initial visit: pre-cyclopegia by an orthoptist, pediatric ophthalmologist, and/or a fourth-year ophthalmology resident; and again post-cycloplegia by a pediatric ophthalmologist.
Gender, refractive error, direction of suspected deviation, age at each visit, and individual suspecting strabismus (pediatrician, parent, teacher, etc.) was recorded for all patients. Family history, developmental history, and birth weight were recorded when available. The quality of the motility exam at each visit was recorded by categorizing the motility exam as poor, good, or excellent. The category was determined either directly from comments in the chart note, or indirectly from the type of measurements recorded or who did the measurement. Exam quality was categorized as poor if only Hirschberg assessment of alignment was obtained, or if a cover test was performed but described as "brief " or "with poor attention". Due to examiner inexperience, all non-cyclopleged motility exams performed by residents only were categorized as poor. Exam quality was categorized as fair/good if a cover test was performed by an orthoptist or pediatric ophthalmologist without any examiner comments regarding visual attention. Exam quality was categorized as excellent if the chart note described the cover test as "prolonged" or "with excellent attention". Exam quality was also categorized as excellent if a cover test was performed in multiple gaze positions.
Type of strabismus, treatment, presence or absence of amblyopia at the time of diagnosis of manifest strabismus, and final sensorimotor status were recorded for those patients who developed manifest strabismus.
Evaluated as possible risk factors for later development of manifest strabismus were low birth weight (defined as five pounds or less), developmental delay, positive family history of strabismus, strabismus noted by the patient's pediatrician, poor quality motility examination at the initial visit, high refractive error, and anisometropia. Refractive error of the more ametropic eye was used for comparative analysis. Anisometropia was defined as a difference of ≥ 1 D spherical equivalent or ≥ 1.5 D of astigmatism. Relative risk of developing strabismus was determined by Chi-Square analysis of each suspected risk factor.
RESULTS
Two hundred sixty-eight patients with the diagnosis of pseudostrabismus were identified. Eighty-five of those patients met the inclusion criteria of having at least one follow-up visit. Two of the 85 patients were excluded on the basis of having other ocular pathology. The remaining 83 patients were included in the study. Thirty-eight were female, 45 were male. Ten of the 83 patients (12%) went on to develop manifest strabismus and 73 (88%) remained orthophoric at all follow-up visits.
The median age at the initial exam was 10 months (mean age 21 months) for those who remained orthophoric at follow-up visits, and 8 months (mean age 16 months) for those who developed strabismus. This difference was not statistically significant. The median age at diagnosis of strabismus was 19 months (mean 20 months, range 7-119 months). Excluding the outlier that was lost to follow-up for several years, therefore not diagnosed until age 9.9 years, the mean age at diagnosis was 20 months. The interval of time between the last normal exam and diagnosis ranged from one month to 71 months with a median of 4.5 months (Table 1) . Mean age at last follow-up visit for those who did not develop strabismus was 38 months (range 9-133 months).
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American Orthoptic Journal 113 There was no statistically significant difference in the accuracy of observation between the pediatricians and lay groups ( Table 2 ). Two of the 83 patients were reported to have an exodeviation. Both remained orthophoric at follow-up visits. The reported direction of deviation was vague or variable in nine subjects, all of whom remained orthophoric at follow-up visits. The remaining 72 subjects were reported to have esodeviations. Of those 72 subjects reported to have esodeviations, one later presented with a hypertropia and nine later presented with esotropia. Six of the nine esotropic patients had accommodative esotropia, two of the nine were lost to follow-up before the response to their hyperopic correction could be assessed. One subject had nonaccommodative esotropia. The subject with nonaccommodative esotropia and the subject with hypertropia were treated with eye muscle surgery.
Seven subjects had a birth weight of 5 pounds or less. None of them developed strabismus. Five (6.8%) of the 73 subjects who did not develop strabismus had a history of developmental delay. Four (40%) of the 10 subjects who later developed strabismus had a history of developmental delay. Family history was positive for strabismus in 27 of 59 subjects without strabismus (45.8%) and in 3 of 8 subjects with strabismus (37.5%). None of these differences are statistically significant.
Five (6.8%) of the 73 subjects that did not develop strabismus were myopic while none of the subjects in the strabismus group were myopic. Mean hyperopia was +2.00 (range +0.37 to +5.87) in the nonstrabismic subjects and was +2.50 (range +1.00 to +5.82) in the strabismic subjects. Anisometropia was present in 5.5% (4/73) of the nonstrabismic subjects and in 10% (1/10) of the strabismic subjects. There is no statistically significant difference in refractive errors between those with and without strabismus. Strabismus developed in 4 of 24 subjects (16.6%) with initial motility exam quality rated as poor, in 3 of 28 subjects (10.7%) with quality rated as good, and in 3 of 31 subjects (9.7%) with quality rated as excellent. This difference is not statistically significant.
Five subjects had multiple normal exams before presenting with manifest strabismus (Table 1) .
Amblyopia was present in two subjects at the time of diagnosis of true strabismus. One patient was subsequently lost to follow-up; the other was successfully treated with patching.
Sensorimotor results at the last follow-up visit are presented for each subject in Table  1 . Two subjects with strabismus were lost to follow-up before the sensorimotor response to treatment could be determined. Of the remaining eight subjects, reliable sensory tests were available for only two subjects. However, based on their motor PSEUDOSTRABISMUS 114
Volume 57, 2007 findings, five subjects (62.5%) had evidence of bifoveal fusion (phoric or intermittent tropia). The remaining three subjects with follow-up had peripheral fusion based on their motor findings, manifesting a deviation less that 8 Δ with an underlying phoria. Of the two that were lost to follow-up, one had evidence of motor fusion at the time of diagnosis and the other did not.
DISCUSSION
The prevalence of strabismus in the patients diagnosed with pseudostrabismus in this study was 12%. Reported prevalence of strabismus in pediatric populations ranges from 1.2% 1,2 to 4.2% 3 . This increased prevalence of strabismus in patients diagnosed with pseudostrabismus suggests they might, as a group, be considered at risk. To determine if the general pediatric patient population in our Children's Hospital clinic might differ from those in other studies, we examined the prevalence of strabismus in our patients with healthy eyes followed for nasolacrimal duct obstructions. The prevalence of strabismus in a group of 82 children (consecutive) with NLD obstruction followed at least to the age of 4 months was 3.7% (3/82). Mean age at last follow-up visit for the 82 subjects was 17 months (range 4-75 months).
One might argue that if the 183 patients who did not return for a follow-up visit were included in the study and counted in the group that did not develop strabismus, the incidence of strabismus would be 3.8% (10/266) and would therefore be within the range of the general pediatric population. We disagree. Inclusion of lost patients in the nonstrabismus group would require the assumption that patients we initially diagnosis with pseudostrabismus remain aligned. The findings in this study of those with follow-up suggest that such an assumption is invalid. Furthermore, we believe that it is inappropriate to conclude that loss to follow-up occurs only when strabismus is absent. We know that we lose patients to follow-up even when the diagnosis of strabismus is made; therefore it is inappropriate to conclude that loss to follow-up occurs only when strabismus is absent. Indeed, we had patients that came only for two exams: the first exam at which the diagnosis of pseudostrabismus was made, and the second exam at which true strabismus was diagnosed. If they had chosen to fail to comply with follow-up recommendations after the first visit rather than after the second, they would have been among those excluded due to no follow-up. This demonstrates that failure to comply with follow-up recommendations does not equate with absence of true strabismus. Furthermore, just as parents of children previously diagnosed with pseudostrabismus elsewhere come to us for a second opinion and are sometimes found to have true strabismus, we anticipate that some of our patients that we diagnose with pseudostrabismus might choose to get an opinion from another ophthalmologist. This request for second opinion would more likely happen if the eyes are in fact crossing and yet we have told the parents that the eyes are not crossing. Such patients would likely continue their care with the ophthalmologist that diagnosed the strabismus and therefore would fall into our "lost to follow-up" category. With all of these factors considered, we concluded that it would be inappropriate to assume that none of the subjects lost to follow-up developed true strabismus and we therefore did not include them in our analysis.
When we see a patient diagnosed with pseudostrabismus return with true manifest strabismus it can be very disconcerting, especially when they become amblyopic and lose stereopsis. It behooves us as clinicians to prevent sensory loss whenever possible. Indeed, the ultimate goal of treatment of any patient with strabismus is to restore or preserve fusion and stereopsis. Since early treatment offers the best op-portunity to reach this goal the challenge is to determine a reasonable follow-up schedule to best ensure that we diagnose the manifest strabismus and begin treatment as early as possible. Our study results did not produce a statistically significant risk factor to aid us in determining which patients with pseudostrabismus in our practice are most likely to go on to develop manifest strabismus. There was, however, a trend for a higher prevalence of later development of strabismus if the initial exam quality is judged to be poor, which suggests that we should follow patients more closely if they are not cooperative enough for a reliable cover test. In addition, there was a very strong trend for developmentally delayed children to later develop manifest strabismus. These two findings, the trend toward increased risk with poor exam quality and with delayed development, are perhaps related since delayed development is often associated with poor visual attention. From the standpoint of statistical significance, however, the results of this study do not support the application of any of the evaluated risk factors in developing a management scheme. A study by Jacobs 4 found ametropia to be a risk factor for development of esotropia in subjects with pseudostrabismus; however, our data did not show any statistical significance with regard to refractive errors. Therefore, although our results show that children diagnosed with pseudostrabismus are at a higher risk of developing strabismus relative to the general pediatric population, our study does not help us determine which children with pseudostrabismus are most at risk.
This study suggests that a management scheme for pseudostrabismus might require multiple follow-up visits to adequately ensure that the patients do not have incipient strabismus. Even after multiple normal eye exams, patients in this study with pseudostrabismus presented later with manifest strabismus. One such subject (#2, Table 2 ) presented at 54 months of age, five months after the last of three "excellent" quality normal exams. It is encouraging, however, that for this subject, bifoveal fusion with good, perhaps normal, stereopsis was preserved.
Developing an appropriate management scheme is complicated by the apparent inconsistency in sensory and visual results in relation to delay in diagnosis. Two subjects (#8 and #1, Table 2 ) had a very short interval of time between the last normal exam and presentation of esotropia (two and three months, respectively). Yet subject #8 had evidence of amblyopia at the time of diagnosis and subject #1 ultimately lost bifoveal fusion. Conversely, subject #9 had a longer (six month) interval between the last normal exam and the diagnosis, yet in spite of this and the age at diagnosis of 12 months, bifoveal fusion was preserved. Overall, bifoveal fusion (evidenced by a phoria or intermittent tropia) was preserved in 5 of the 10 subjects. It is important to point out that our management strategy for patients diagnosed with pseudostrabismus is to reexamine them in six months or less. The interval of time between the last normal exam and diagnosis ranged from one month to 71 months with a median of 4.5 months. The final sensory outcome might be poorer with a less aggressive follow-up plan that allows longer delays in diagnosis and treatment.
It might be tempting to incorporate parental observations into the follow-up schedule, recommending follow-up only if the family noted the crossing to become worse in terms of size or frequency. However, had this strategy been applied to our management plan, seven of the ten of the strabismic subjects would have had a longer delay in diagnosis and treatment. At the visit at which manifest strabismus was diagnosed, one family reported that the crossing had resolved, two families reported an improvement in the crossing and four reported no change. Only three re-ported a worsening of the crossing. Interestingly, even the family of the patient diagnosed with intermittent hypertropia reported no change in the crossing.
CONCLUSION
The results of this study fail to provide us with identifiable risk factors to guide us in management of patients diagnosed with pseudostrabismus. Patients with developmental delay and patients that are especially difficult to examine are perhaps at higher risk. The results do suggest that patients diagnosed with pseudostrabismus differ from the general pediatric population and from other children followed with normal eye exams with regard to prevalence of strabismus. Therefore, children diagnosed with pseudostrabismus can be considered as at risk of developing true strabismus and its sequelae. We are currently conducting a prospective study in which additional tests are performed when strabismus is suspected by the family or pediatrician, but not detected by conventional cover test techniques. However, until techniques for improved detection are identified, the family should be alerted to the pos-PRITCHARD American Orthoptic Journal 117 sibility that true strabismus might indeed be in the process of development and follow-up should reflect the increased incidence of manifest strabismus. Additional studies are needed to confirm the findings in this group of 83 subjects and to further explore possible risk factors that might assist in developing an appropriate management strategy for patients diagnosed with pseudostrabismus.
